M Bayes, X Rabasseda, JR Prous - Methods and findings in experimental and clinical …, 2006 - journals.prous.com Contributing Editors: P. Cole, C. Orellana, JA Vallès, RM a . Antonijoan, KP
Mohana Priya, M. Priya, V. Renuga, R. Sree Lekha, B. Priya, A. Tomillero, G.
Krithiga and E. Banu Rekha. Cited by 148 - Related articles - All 9 versions
- ►endojournals.org BL Wajchenberg - Endocrine reviews, 2007 - Endocrine Soc There is a progressive deterioration in ß-cell function and mass in type 2
diabetics. It was found that islet function was about 50% of normal at the time
of diagnosis, and a reduction in ß-cell mass of about 60% was shown at ... Cited by 100 - Related articles - BL Direct - All 7 versions
R Eldor, E Stern, Z Milicevic, I Raz - Diabetes research and clinical practice, 2005 - Elsevier Type 2 diabetes is a disease characterised by peripheral insulin resistance, as
well as by pancreatic beta cell dysfunction. This process is in part due to
elevated blood glucose and free fatty acids – termed glucolipotoxicity. ... Cited by 23 - Related articles - All 9 versions
DS Bell, F Ovalle - Diabetes Obesity and Metabolism, 2006 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 16 - Related articles - BL Direct - All 4 versions
- ►infodiabetes.it [PDF] P Hollander, D Yu, HS Chou - Archives of Internal Medicine, 2007 - archinte.highwire.org You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 13 - Related articles - BL Direct - All 7 versions
- ►physiology.org K Kos, AL Harte, S James, DR Snead, JP O' … - American Journal of Physiology- Endocrinology And …, 2007 - Am Physiological Soc NPY is an important central orexigenic hormone, but little is known about its
peripheral actions in human adipose tissue (AT) or its potential paracrine
effects. Our objective was to examine NPY's role in AT, specifically ... Cited by 13 - Related articles - BL Direct - All 3 versions
IW Campbell, S Mariz - Diabetes research and clinical practice, 2007 - Elsevier Progressive β-cell dysfunction and β-cell failure are fundamental pathogenic
features of type 2 diabetes. Ultimately, the development and continued
progression of diabetes is a consequence of the failure of the β-cell to ... Cited by 13 - Related articles - All 11 versions
- ►adisonline.com [PDF] K Wellington - Drugs, 2005 - pt.wkhealth.com ▴ Antihyperglycaemic combination therapy is often required to achieve
effective glycaemic control. A fixed-dose formulation of rosiglitazone/metformin
was recently approved in the EU and the US for the treatment of type 2 ... Cited by 12 - Related articles - BL Direct - All 6 versions
H Richardson, SC Campbell, SA Smith, WM … - Diabetologia, 2006 - Springer Abstract Aims/hypothesis: Rosiglitazone and metformin are two oral
antihyperglycaemic drugs used to treat type 2 diabetes. While both drugs have
been shown to improve insulin-sensitive glucose uptake, the direct effects ... Cited by 12 - Related articles - BL Direct - All 5 versions
BJ Goldstein - International journal of clinical practice, 2006 - interscience.wiley.com Recent clinical research has provided a wealth of information to support optimal
management strategies in type 2 diabetes mellitus (T2DM). In particular, outcome
studies appropriately have had an increasingly important impact on clinical ... Cited by 13 - Related articles - BL Direct - All 5 versions
